HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Takeda Selected Research

Corticosterone

11/2023Cytoprotective effects of Hangekobokuto against corticosterone-induced cell death in HT22 cells.
1/2016Corticosterone Inhibits the Proliferation of C6 Glioma Cells via the Translocation of Unphosphorylated Glucocorticoid Receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Takeda Research Topics

Disease

29Type 2 Diabetes Mellitus (MODY)
05/2024 - 09/2002
21Neoplasms (Cancer)
05/2023 - 02/2005
19Body Weight (Weight, Body)
12/2021 - 01/2013
15Anorexia
01/2021 - 06/2008
14Colitis
01/2023 - 07/2002
11Inflammation (Inflammations)
03/2024 - 03/2002
10Gastroesophageal Reflux (GERD)
01/2021 - 08/2004
8Pain (Aches)
07/2023 - 11/2006
8Myocardial Infarction
04/2013 - 09/2002
6Weight Loss (Weight Reduction)
01/2020 - 05/2002
5Chronic Renal Insufficiency
05/2024 - 01/2019
5Diabetes Mellitus
02/2022 - 09/2002
5Dyspepsia (Indigestion)
01/2021 - 10/2010
5Infections
11/2012 - 03/2004
4Mental Disorders (Mental Disorder)
11/2023 - 08/2010
4Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017 - 07/2002
4Nephritis
02/2011 - 02/2007
3Mitochondrial Diseases (Mitochondrial Disease)
05/2023 - 01/2013
3Sarcopenia
05/2023 - 02/2018
3Stomatitis
04/2019 - 09/2013
3Hypertension (High Blood Pressure)
01/2019 - 02/2002
3Anxiety Disorders (Anxiety Disorder)
04/2018 - 11/2004
3Sleep Initiation and Maintenance Disorders (Insomnia)
04/2018 - 09/2014
3Hypoxia (Hypoxemia)
01/2017 - 01/2013
3Diarrhea
01/2015 - 07/2007
3Atrial Fibrillation
07/2014 - 11/2003
3Pathologic Constriction (Stenosis)
08/2009 - 01/2004
3Heart Failure
04/2009 - 02/2002
3Laryngopharyngeal Reflux
08/2008 - 04/2006
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2024 - 09/2019
2Muscular Atrophy (Muscle Atrophy)
05/2023 - 06/2022
2Atrophy
05/2023 - 06/2022
2Asthma (Bronchial Asthma)
01/2023 - 03/2002
2Fibromyalgia (Fibrositis)
01/2023 - 12/2019
2Non-alcoholic Fatty Liver Disease
06/2022 - 03/2020
2Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 03/2003
2Pruritus (Itching)
01/2022 - 01/2019

Drug/Important Bio-Agent (IBA)

15liu-jun-zi-tangIBA
01/2021 - 06/2008
12GhrelinIBA
10/2020 - 01/2010
11Cisplatin (Platino)FDA LinkGeneric
05/2023 - 06/2008
11Insulin (Novolin)FDA Link
02/2022 - 12/2002
10Glucose (Dextrose)FDA LinkGeneric
05/2024 - 08/2002
10Dextran SulfateIBA
12/2018 - 07/2002
9AcidsIBA
03/2024 - 02/2002
9Macrophage Migration-Inhibitory FactorsIBA
12/2017 - 07/2002
8SodiumIBA
05/2024 - 02/2016
8Proteins (Proteins, Gene)FDA Link
03/2024 - 08/2002
8Messenger RNA (mRNA)IBA
01/2022 - 07/2002
7Sodium-Glucose Transporter 2 InhibitorsIBA
05/2024 - 05/2016
7Sitagliptin Phosphate (Januvia)FDA Link
03/2020 - 10/2012
7Hemoglobins (Hemoglobin)IBA
03/2020 - 07/2015
7Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 - 09/2005
7Therapeutic UsesIBA
01/2017 - 09/2005
6ipragliflozinIBA
09/2020 - 02/2016
5SymportersIBA
12/2023 - 02/2016
5Serotonin (5 Hydroxytryptamine)IBA
01/2013 - 01/2011
4Glucagon-Like Peptide-1 Receptor AgonistsIBA
01/2024 - 03/2022
4Sodium-Glucose Transport ProteinsIBA
11/2023 - 01/2019
4Analgesics (Analgesic Drugs)IBA
07/2023 - 01/2019
4Yi-Gan SanIBA
04/2018 - 09/2013
4Blood Glucose (Blood Sugar)IBA
02/2016 - 10/2012
3Plant ExtractsIBA
11/2023 - 02/2002
3CytokinesIBA
11/2023 - 07/2002
3SteroidsIBA
01/2023 - 02/2007
3Zinc SulfateFDA Link
01/2023 - 11/2005
3Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 12/2018
3Estrogen ReceptorsIBA
10/2020 - 04/2015
3Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
05/2019 - 02/2016
3LipidsIBA
07/2017 - 01/2015
3Peptides (Polypeptides)IBA
04/2015 - 07/2012
3Proton Pump InhibitorsIBA
10/2014 - 08/2004
3Lymphotoxin-alpha (Lymphotoxin)IBA
04/2013 - 06/2008
3salicylhydroxamic acid (SHAM)IBA
01/2013 - 01/2011
3DNA (Deoxyribonucleic Acid)IBA
11/2012 - 08/2010
3N- (3,4- dimethoxyphenethyl)- N- methyl- 3- (3- pyridyl)- 2- propenamideIBA
12/2010 - 01/2010
3SolutionsIBA
01/2010 - 09/2005
3Immunoglobulin A (IgA)IBA
10/2009 - 08/2003
3Heat-Shock Proteins (Heat-Shock Protein)IBA
11/2006 - 09/2005
3geranylgeranylacetone (teprenone)IBA
03/2006 - 09/2005
2Glucagon-Like Peptide-1 ReceptorIBA
05/2024 - 04/2014
2Brain-Derived Neurotrophic Factor (BDNF)IBA
03/2024 - 08/2010
2CorticosteroneIBA
11/2023 - 01/2016
2GlucocorticoidsIBA
11/2023 - 04/2007
2Capsaicin (Zostrix)FDA Link
07/2023 - 01/2022
2Reactive Oxygen Species (Oxygen Radicals)IBA
05/2023 - 06/2022
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2023 - 02/2010
2Adenosine Triphosphate (ATP)IBA
06/2022 - 11/2012
2Dinoprostone (PGE2)FDA Link
01/2022 - 01/2015
2bu-zhong-yi-qi-tangIBA
01/2022 - 09/2013
2CanagliflozinIBA
12/2021 - 01/2020

Therapy/Procedure

30Therapeutics
05/2024 - 01/2002
11Drug Therapy (Chemotherapy)
05/2024 - 06/2008
10Glycemic Control
03/2020 - 03/2009
8Kampo Medicine (Kampo)
01/2015 - 10/2010
5Transplantation
01/2017 - 01/2015
4Mesenchymal Stem Cell Transplantation
01/2017 - 01/2015
4Oral Administration
12/2010 - 09/2005
3Chemoradiotherapy
04/2019 - 08/2009
3Aftercare (After-Treatment)
01/2017 - 07/2007
3Stents
08/2009 - 01/2004